Impax hires new compliance officer; MIT continuous manufacturing start-up gets new home;

> Impax Laboratories ($IXPL) has named Deborah M. Penza, an Actavis alum, as chief compliance officer. Release

> Continuus Pharmaceuticals, which designs, builds and runs processes for the continuous manufacturing of small-molecule pharmaceuticals, and which grew from the collaboration between the Massachusetts Institute of Technology and Novartis ($NVS), has moved to Woburn, MA. Report

> A man with both U.K. and Pakistani citizenship has been indicted for operating websites that sold unapproved drugs that the sites claimed could cure a number of diseases. Release

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.